Lanean...

Profile of the Pleximmune blood test for transplant rejection risk prediction

The Pleximmune™ test (Plexision Inc., Pittsburgh, PA, USA) is the first cell-based test approved by the US FDA, which predicts acute cellular rejection in children with liver- or intestine transplantation. The test addresses an unmet need to improve management of immunosuppression, which incurs grea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Expert Rev Mol Diagn
Egile Nagusiak: Sindhi, Rakesh, Ashokkumar, Chethan, Higgs, Brandon W, Levy, Samantha, Soltys, Kyle, Bond, Geoffrey, Mazariegos, George, Ranganathan, Sarangarajan, Zeevi, Adriana
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965161/
https://ncbi.nlm.nih.gov/pubmed/26760313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737159.2016.1139455
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!